Expert Pitch

Thai king reinstates ‘disappeared’ royal consort as protests continue

Cornell University
3-Sep-2020 1:35 PM EDT, by Cornell University

In the wake of the largest anti-government protests in Thailand since 2014, the Thai King Vajiralongkorn reinstated his Royal Noble Consort, Sineenat Wongvajirapakdi, after having demoted her in October of 2019.  

Tamara Loos, professor of history and Thai studies at Cornell University, says that the King’s treatment of Sineenat represents one of the many reasons why protestors in Thailand have targeted the monarchy for reform.

Bio: https://history.cornell.edu/tamara-loos

Loos says:

“Several days ago, Thailand’s King Vajiralongkorn had Sineenat Wongvajirapakdi reinstated as his Royal Noble Consort, the first in nearly a century in a country where polygyny is not legal. Last year, after the king married Suthida Tidjai and made her his Queen, he boldly broadcasted Sineenat’s appointment as his consort on his birthday. Within a few short months, he publicly demoted her for being disloyal, ambitious, self-promoting, and rivaling the queen. No one heard from her again, generating speculation that she had been disappeared, imprisoned or murdered.  She would not be the first person who ran afoul of the authorities to have disappeared since the monarch ascended the throne. However, she has now been reinstated as ‘unblemished,’ and has had her titles and ranks restored ‘as if it she had never been stripped’ of them. Magic.

 “What does it mean that King Vajiralongkorn can appoint a consort, openly ‘disappear’ her, then snap his fingers and have her brought to him directly at his luxurious estate in Germany, where he spends most of his time? It means there are no consequences for the king’s behavior, but dire consequences for those close to him and those who confront him. It means that law cannot touch him nor can it protect others from him. The king’s treatment of Sineenat as a possession, put away and taken out at his will, is one of many reasons why protesters in Thailand have broached the taboo topic of the monarchy in recent months.

“In particular, Thailand’s younger generation demands a new moral compact with the monarchy—one in which the king could be subject to Thai law. Sineenat and her family remain in the crosshairs of the king’s lethal scope, rendering moot any speculation that her reinstatement is one she freely chooses.”




Filters close

Showing results

110 of 4573
Released: 15-Jan-2021 5:40 PM EST
Research Links Social Isolation to COVID-19 Protocol Resistance
Humboldt State University

As health officials continue to implore the public to wear masks and practice social distancing, recent research by Humboldt State University Psychology Professor Amber Gaffney provides key insights into connections between social isolation, conspiratorial thinking, and resistance to COVID-19 protocols.

Newswise: Rapid blood test identifies COVID-19 patients at high risk of severe disease
Released: 15-Jan-2021 5:35 PM EST
Rapid blood test identifies COVID-19 patients at high risk of severe disease
Washington University in St. Louis

Scientists at Washington University School of Medicine in St. Louis have shown that a relatively simple and rapid blood test can predict which patients with COVID-19 are at highest risk of severe complications or death. The blood test measures levels of mitochondrial DNA, which normally resides inside the energy factories of cells. Mitochondrial DNA spilling out of cells and into the bloodstream is a sign that a particular type of violent cell death is taking place in the body.

Released: 15-Jan-2021 2:55 PM EST
COVID-19 deaths really are different. But best practices for ICU care should still apply, studies suggest.
Michigan Medicine - University of Michigan

COVID-19 deaths are indeed different from other lung failure deaths, according to two recent studies, with 56% of COVID-19 patients dying primarily from the lung damage caused by the virus, compared with 22% of those whose lungs fail due to other causes. But, the researchers conclude, the kind of care needed to help sustain people through the worst cases of all forms of lung failure is highly similar, and just needs to be fine-tuned.

Released: 15-Jan-2021 2:50 PM EST
45% of adults over 65 lack online medical accounts that could help them sign up for COVID-19 vaccinations
Michigan Medicine - University of Michigan

As the vaccination of older adults against COVID-19 begins across the country, new poll data suggests that many of them don’t yet have access to the “patient portal” online systems that could make it much easier for them to schedule a vaccination appointment. In all, 45% of adults aged 65 to 80 had not set up an account with their health provider’s portal system.

Released: 15-Jan-2021 1:30 PM EST
New England Journal of Medicine publishes COVID-19 treatment trial results
University of Texas at San Antonio

A clinical trial involving COVID-19 patients hospitalized at UT Health San Antonio and University Health, among roughly 100 sites globally, found that a combination of the drugs baricitinib and remdesivir reduced time to recovery, according to results published Dec. 11 in the New England Journal of Medicine.

Released: 15-Jan-2021 12:40 PM EST
DNA test can quickly identify pneumonia in patients with severe COVID-19, aiding faster treatment
University of Cambridge

Researchers have developed a DNA test to quickly identify secondary infections in COVID-19 patients, who have double the risk of developing pneumonia while on ventilation than non-COVID-19 patients.

Released: 15-Jan-2021 12:30 PM EST
Fight CRC To Present Research Findings on The Impact of COVID-19 on the Colorectal Cancer Community at 2021 GI ASCO
Fight Colorectal Cancer

Fight Colorectal Cancer presents abstract at Gastrointestinal Cancer Symposium highlighting the need to address the barriers and opportunities for care within the colorectal cancer community during the COVID-19 pandemic

Released: 15-Jan-2021 12:25 PM EST
Technion to Award Honorary Doctorate to Pfizer CEO Dr. Albert Bourla
American Technion Society

Israel's Technion will award an honorary doctorate to Pfizer CEO and Chairman Dr. Albert Bourla, for leading the development of the novel vaccine against SARS-CoV-2, the virus that causes COVID-19. The honorary doctorate will be conferred at the Technion Board of Governors meeting in November 2021.

Released: 15-Jan-2021 11:30 AM EST
UW researchers develop tool to equitably distribute limited vaccines
University of Wisconsin-Madison

Researchers at the University of Wisconsin School of Medicine and Public Health and UW Health have developed a tool that incorporates a person’s age and socioeconomic status to prioritize vaccine distribution among people who otherwise share similar risks due to their jobs.


Showing results

110 of 4573

close
0.9601